Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Income Quality Over TimeStable
Percentile Rank40
3Y CAGR-2.1%
5Y CAGR+5.1%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-2.1%/yr
Annual compound
5Y CAGR
+5.1%/yr
Recent deceleration
Percentile
P40
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
20250.92-1.5%
20240.94-17.2%
20231.13+15.1%
20220.98+30.7%
20210.75+4.3%
20200.72-